Evidence suggests that APOE4 carries out damaging AD-related phenotypes in a TLR4-dependent pathway [42,43,44]: LPS brain infusion in APOE4 mice results in increased NFκB activation and IL-1β secretion compared to APOE3 counterpart [43,44]. This evidence concerns the gene NFKB1 and Alzheimer disease.